INTRODUCTION
A computer optimization technique, based on responsesurface methodology has proven to be a useful approach for selecting pharmaceutical formulations. Factorial designs are the most popular response surface designs [1] [2] . A factorial design for two factors at three levels (3 2 ) which is equivalent to a central composite design (CCD) for two factors was selected to optimize varied response variables viz. release rate exponent (n), t50%, k, amount of drug released in 12h (Rel12h) and mean dissolution time MDT [3] [4] [5] .
Chlorphenirame maleate is an alkylamine derivative with the properties and uses of the antihistamines and generally causes less sedation. It antagonizes actions of histamine at the H1 receptors. Doses -Usually 4mg, 3-4 times daily, higher doses up to 36mg daily, in sustained release preparations are given. It is used in conditions like Allergic Disorders , Renal failure ,Common Cold and others 6, 7 .
Matrix tablet is the least complicated approach in devising a sustained release dosage form and involves the direct compression of blend of drug, retardant material, and additives to form a tablet in which the drug is embedded in a matrix core of the retardant. Hydrophilic matrices are well mixed composite of one or more drugs with a hydrophilic polymer. Hydrophilic matrices possesses major advantages over other alternatives in developing oral controlled release drug delivery as they have a capacity to incorporate large doses of drugs, these can't be disintegrated throughout the GI tract so the dose dumping is not there [8] [9] [10] [11] [12] .
In the current study different grades of HPMC like K4M, K15M and K100M were selected during preliminary studies for regulating the release of the drug chlorphenirame maleate. Two polymers HPMCK4M and HPMCK15M were further selected for optimization studies 13-15. Sustained release of drug is required to reduce the frequency of administration. Therefore the object of present study is to enable a simpler method of manufacture of tablets to provide sustained release of the drug content up to 12 hrs.
MATERIALS UNDER METHODS
Chlorphenirame maleate was obtained as a gift sample from Promed Labs. Ltd, Indore, (M.P.), HPMC(K4M, K15M, K100M) were provided by Colorcon India Ltd., Goa, dicalcium phosphate, microcrystalline cellulose (Avicel PH101), purified talc , magnesium stearate and all other reagent used were of analytical grade.
Pre-optimization studies
Nine formulations employed for pre-optimization investigations containing different ratios of HPMCK4M, HPMCK15M and HPMCK100M, keeping the total tablet weight constant at 120mg. The tablets were prepared by direct compression. The values of response variables viz. n, rel12h, MDT, t50%, t70% and t80% were studied to help in choosing the best possible combination for further optimization studies.
Factorial Design
The 3 2 factorial designs were selected using two factors (polymers) at three levels and the factor levels were suitably coded. Nine formulations were prepared as per the design and coded F1-F9. The two polymers HPMC K4M and HPMC K15M were selected and their limits were chosen for subsequent detail studies using the factorial design. The amount of drug, magnesium stearate, MCC and talc were kept constant while dicalcium phosphate was taken in sufficient quantity to maintain a constant tablet weight of 120mg. The translation of the coded factor level as amount of ingredients is listed in Table (1). 
Preparation of Tablets and Physical Evaluation
Tablet batches consisting of 100 tablets were prepared by direct compression method. All the product and process variables other than the concentration of two polymers were kept constant. The composition of nine formulations F1-F9 as per factorial design during optimization studies are shown in Table ( 2a.). Ten tablets from each batch were weighed individually and subjected to physical evaluation.
Dissolution Studies
Dissolution studies were carried out for all the nine formulations in triplicate, employing dissolution USPXXII paddle apparatus, using distilled water pH 6.3 as the dissolution medium at 50 rpm and 37  0.5 0 C. An aliquot of sample was periodically withdrawn at suitable time intervals and volume replaced with equivalent amounts of plain dissolution medium. The samples were analyzed at 261 nm.
Data Analysis
The raw data obtained from in vitro dissolution was analyzed using the software. The software has in built provisions for calculating the values of amount of drug release, percentage of drug release, log fraction released at various time interval, log time, mid-point of time intervals and rate of drug release [16] [17] [18] .
The software also calculates the kinetic constant (K), the diffusional release exponent (n) using logarithmic transformation, coefficient of determination (R 2 ), standard error of estimation (SEOE), significance test,'t' values and 'p' valuesare shown in Table (2b) . These values are calculated from the interpolation option the graphs. The response variables, which were considered for optimization included, n, mean dissolution time (MDT), release at 12 th hr (rel 12 h), t50% were also calculated. Finally, the prognosis of optimum formulation was conducted in two stages. First, a feasible space was located and second, an exhaustive grid search was conducted to predict the possible solutions. The optimum formulation were selected by the critical evaluation of the tabulated grid search values .
Preparation of Predicted optimum Formulation
The tablet formulations were compressed using the chosen optimal composition and evaluated for physical test, tablet assay and dissolution performance. The observed and predicted responses were critically compared. 
RESULTS

Pre-optimization Studies Results
The data obtained during the pre-optimization studies reveals that as the molecular weight or the viscosity of the polymer increases, release rate of the drug from the formulation decreases. These studies help in the selection of the appropriate range of polymer for the further optimization studies.
Physical Evaluation and Assay of Tablet
The tablet weights of all the nine batches vary between 120 and 121 mg, diameter around 7.22mm, thickness between 2.11 mm to 2.14 mm and tablet hardness between 5.5 to 5.9 Kg. The assay was performed taking 20 tablets weighed and powdered equivalent to about 4mg of chlorphenirame maleate shaken with 20ml of 0.05M sulphuric acid for 5minutes then added 20ml of ether and filtered the acid layer. The ether layer was extracted with two quantities each of 10ml of 0.05M sulphuric acid. The combined acid extracts were made alkaline to litmus paper with 1M sodium hydroxide and extracted with two quantities each of 50 ml of ether. Each ether extract was washed with the water and 0.25M sulphuric acid, diluted and measured the absorbance of the resulting solution at about 265nm. The assay values varied between 95.83% to 98.75% . The tablet friability ranged between 0.5 to 0.8%. The physical parameters of the manually compressed tablets were found within control.
Release Profile Studies
The dissolution parameters of nine formulations as per design containing HPMCK4M and HPMCK15M polymer combination with different ratios, obtained are shown in the Table ( 2). The release pattern between percent drug release vs. time and plot between cumulative percent drug release vs square root of time (Higuchi Plot) are shown in Fig. (1) and Fig. (2) , respectively. 
Response Surface Analysis -Calculation of Coefficient
The coefficients of the polynomial equations for responses n, k, Rel 12hr, MDT and t50% are listed The coefficient of the above equation was calculated by regression using the transformed data taken for Factor X1(HPMCK4M) and Factor X2 (HPMCK15M) as shown in Table( 1).
The value of R 2 is quite high for Rel12h, t50%, n and MDT so for these responses, the polynomial equations form excellent fits to all the experimental data and statistically valid Table ( 3). 
Search for Optimum Formulations
The criterion for selection of suitable feasible region was primarily based on highest possible values of n, Rel 12 hr, MDT and t50%. Two regions were selected on the basis of dissolution parameters obtained during optimization studies of formulations F1-F9. The exel sheet was used to predict and determine the responses between the Region 1 and further Region 2, termed as feasible regions for factorX1 and FactorX2 (HPMCK4M and HPMCK15M). Region 1 rel 12 hr >90%; n > 0.460; MDT > 3.1; t50% > 2.5 hr.
Region 2
rel 12 hr >96; n > 0.49; MDT > 3.8; t50% > 3 hr
The predicted values for the responses were noted and are shown in Table (4a) . Based on the predicted values the levels were decoded and factor values were determined (refer Table ( 1) . Values obtained for HPMCK4M were 27.2 mg and HPMCK15M were 18.15 mg. using these amounts tablets of optimum formulation was prepared and subjected to dissolution studies. The dissolution parameters obtained for optimum formulation are shown in Table (4b) . 
Comparison of Optimum Formulation
The results of the physical evaluation and tablet assay of the optimum formulation were within limits. Dissolution parameters like n, MDT, Rel 12n and k were tabulated for optimized matrix tablets formulation and shown in Table ( 4b.). The plot between percent drug release and time of the optimized formulation is shown in Fig. (3) .
The comparison of the observed responses with anticipated responses along with percent error are listed in Table ( The values of MDT showed that with increasing total polymer content resulted in the increase of mean dissolution time. MDT is used to characterize drug release rate from a dosage form and indicates the drug release retarding efficiency of polymer.
Comparisons of the observed responses with that of the anticipated responses along with percentage error for dissolution parameters like n and Rel 12h of optimized matrix tablets formulation shows the prognostic ability of matrix tablet formulations of Chlorpheniramine maleate using optimization method and is validated.
CONCLUSION
Chlorpheniramine maleate matrix tablets containing combination of polymers HPMCK4M and HPMCK15M, confirms excellent promises for drug release prolongation.
Results of the dissolution studies for optimized formulation fulfilled maximum requisites because of better regulation of release rate. Rational use of optimization methodology helped to predict the best possible formulations and confirms the prognostic ability of optimization method. Using the traditional methods, however, the best formulation might have skipped the observations of the formulation scientist. Conclusively, the current study attained the successful design, development, optimization and formulation of chlorpheniramine maleate Tablets.
